Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition
The FEBS Journal · 2025
DOI: 10.1111/febs.70039 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Oney Ortega Granda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France. Hauptthemen laut MEDLINE: SARS-CoV-2, Viral Nonstructural Proteins, Antiviral Agents. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: French Infrastructure for Integrated Structural Biology, European Synchrotron Radiation Facility, Innovative Medicines Initiative 2 Joint Undertaking (JU).
Abstract (Originalsprache)
The severe acute respiratory syndrome coronavirus (SARS‐CoV/CoV‐2) genome encodes 16 non‐structural proteins (nsps), which coordinate cell remodeling, virus replication and participate in viral evasion. Notably, nsp3 contains a protein module termed Macro domain, which carries IFN antagonist activity that interferes with host innate immunity response. This domain is able to bind and hydrolyze ADP‐ribose derivatives. This activity is correlated to viral escape and thus makes Macro domains a valuable therapeutic target. In the present paper, we report a SARS‐CoV Macro domain structure in complex with a MOPS molecule. Based on our structural data, molecular docking was performed on a set of MOPS analogs in the ADP‐ribose binding pocket. We present an ELISA‐based assay to select hits based on the inhibition of recombinant SARS‐CoV/CoV‐2 Macro domain‐ADP‐ribose complex formation. Among the tested analogs, MOPSO and CAPSO are the more efficient in inhibiting ADP‐ribose‐binding. Structural analysis of these molecules in the ADP‐ribose pocket reveals potential interactions with amino acid residues involved in the coordination of ADP‐ribose. Overall, these findings suggest that MOPSO and CAPSO bear potential to be used as a scaffold for the design of Macro domain‐specific inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France.
- European Virus Bioinformatics Center, Jena, Germany.
ORCID-Profile: François Ferron, Nadia Rabah
Förderung
- French Infrastructure for Integrated Structural Biology
- European Synchrotron Radiation Facility
- Innovative Medicines Initiative 2 Joint Undertaking (JU)
- Initiative d'Excellence d'Aix-Marseille Université
Zitieren
APA
Ortega Granda, O., Alvarez, K., Morin, B., Canard, B., Ferron, F., & Rabah, N. (2025). Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition. The FEBS Journal. https://doi.org/10.1111/febs.70039
Vancouver
Ortega Granda O, Alvarez K, Morin B, Canard B, Ferron F, Rabah N. Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition. The FEBS Journal. 2025. doi:10.1111/febs.70039
BibTeX
@article{OrtegaGranda2025,
author = {Ortega Granda, Oney and Alvarez, Karine and Morin, Benjamin and Canard, Bruno and Ferron, François and Rabah, Nadia},
title = {Derivatives of MOPS : promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70039}
}
EUVIMED